Global RNA Therapeutics Market
RNA Therapeutics Market Research Report 2023: Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Global Forecast to 2028
January 31, 2024 05:59 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious...
22157.jpg
Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs
January 25, 2024 09:54 ET | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
Global RNA-based Therapeutics Market
RNA-based Therapeutics Market Outlook Report, 2023-2034: Personalized Medicine Adoption, Investment Inflows, and Pharma Collaborations Fueling Global Industry Growth
January 24, 2024 14:22 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global RNA-based Therapeutics Market" report has been added to ResearchAndMarkets.com's offering. The Global RNA-based Therapeutics Market was...
RNA Therapeutics Market and RNA Vaccines Market
Next-Generation RNA Therapeutics and Vaccines Surge: Promising Modalities and Clinical Trials Fueling Growth in the RNA Market
October 12, 2023 05:43 ET | Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical...
Global MicroRNA Research Tools, Diagnostics & Therapeutics Market
MicroRNA Research Tools, Diagnostics and Therapeutics Global Market Research Report 2023
August 30, 2023 04:58 ET | Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The miRNA tools...
Global RNAi Drug Delivery Market
RNAi Drug Delivery Technologies and Global Market Analysis Report 2023: Historic Market Revenue from 2020 to 2022, Estimates for 2023, and CAGR Projections through to 2028
August 29, 2023 07:08 ET | Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "RNAi Drug Delivery: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global RNAi drug delivery...
22157.jpg
Global RNA Analysis Market Research 2023: A $20+ Billion Market by 2030 - Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
July 06, 2023 10:13 ET | Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray,...
Global Bacterial & Plasmid Vectors Market
Bacterial and Plasmid Vectors Global Market Report 2023: Increasing Prevalence of Cancer and Infectious Diseases Drives Growth
June 09, 2023 09:38 ET | Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Bacterial And Plasmid Vectors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
22157.jpg
Global Exosome Market Research Report 2023-2030: Currently 204 Clinical Trials - 114 Trials are Evaluating Exosome-based Therapeutics / 74 trials are Testing Exosome-Based Diagnostic Tests
June 01, 2023 03:33 ET | Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering. Globally,...
Investor Series-Opportunities in RNA Therapeutics Market
RNA Therapeutics Markets, 2035 - Technical and Financial Perspective on How the Opportunity in this Domain is Likely to Evolve
April 24, 2023 03:33 ET | Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in RNA Therapeutics Market" report has been added to ResearchAndMarkets.com's offering. The Investor Series:...